Our leadership team
Our world-class leadership team has decades of experience with emerging and established technology, SaaS, and life science organizations. These trusted executives are adept at guiding companies through rapid expansion and now apply those winning strategies to power ArisGlobal’s next phase of growth. Meet our global experts below and learn more about career opportunities with our team.

Mike Gordon
Chief Executive Officer, ArisGlobal
Chairman of the Board
Mike Gordon is the CEO of ArisGlobal, a global life sciences technology provider with innovative and market leading solutions. He also serves as Chairman of its Board since 2020. Mike is a seasoned professional with a well-established background in global leadership roles, mainly within technology-focused organizations. Prior to taking Arisglobal’s CEO role in 2022 he was CEO of Altus Group, a public company in the Commercial Real Estate sector, where he led its transformation into a cloud-based software, data, and analytics company through a renewed focus on sales, reworking solutions, and improving customer retention and satisfaction. Preceding Altus Group, Mike served on the leadership team at Callcredit Information Group as CEO, where he oversaw a successful transformation of the business and an eventual sale to Transunion. Before Callcredit Information, Mike served as FICO’s Executive Vice President of Sales, Services, and Marketing, after working in various roles of increasing responsibility across the company’s banking, insurance, retail, health care and pharmaceutical markets. Before joining FICO in 2005, he spent more than 13 years in the financial services industry. As a vice president at Capgemini (formerly Ernst & Young Consulting LLP) his competency was in providing strategic and operational solutions to banking and insurance providers, leading the Insurance Center of Excellence and Solutions.
Mike also currently serves on the board of directors of three technology companies, Fintech, Hometrack, and Constructonline. He received a BS in Industrial Engineering / Operations Research from Northwestern University and an MBA in Finance and Business Economics from The University of Chicago Graduate School of Business.

Pat Jenakanandhini
Chief Product Officer
Pat Jenakanandhini serves as ArisGlobal’s Chief Product Officer, where he oversees all product strategy and management functions. Prior to ArisGlobal, Pat served as Senior Vice President of Products at Accruent and Chief Technology Officer at BlueCielo, acquiring several years of experience building and delivering SaaS products including serving. During his tenure at Accruent, the company completed 5 acquisitions, built a strong product strategy driving growth that eventually led to Accruent being acquired by Fortive, a large publicly listed company. At BlueCielo, Pat was responsible for driving the transformation of the product, the business and the culture of product & engineering teams to focusing on SaaS. Pat is passionate about building great software that delights users, solves real business problems and provides a superior user experience. Pat lives just outside Boston, MA with his wife, 2 kids and dog. Pat loves building things, home automation, playing video games, and traveling the world. He has an MBA in Finance and dual degrees in Computer Science and Process & Piping Design.

Aman Wasan
Chief Commercial Officer
Wasan is an expert in general management and commercial leadership with a deep understanding and knowledge of drug safety and clinical research. Since joining ArisGlobal in 2018, Wasan has excelled in six different positions, most recently as Senior Vice President of Global Commercials, where he managed global enterprise business. Before joining the ArisGlobal team, Wasan worked for Bioclinica as the company’s Global Head of Safety and Regulatory Services.

Julie Springer
Chief Marketing Officer
Julie is a seasoned marketing executive with over 30 years of experience in corporate, business and consumer marketing. She has a proven track record driving transformational business objectives, specifically on exits from private equity to the public market. She has contributed to M&A efforts, IPOs, and other strategic business initiatives, including leading all marketing and communications of TransUnion’s 2015 successful IPO. She has held leadership positions at other organizations such as Fast Radius and Experian where she led companywide projects in brand & reputation, performance & revenue, net promoter score, and change management.

Glenn Renzulli
Chief Financial Officer
Glenn brings over 15 years of executive leadership across various industries. He has a strong background in scaling and supporting software and services businesses, as well as an extensive M&A experience, including multiple exit transactions, public offerings, and acquiring and integrating new entities.
Before joining ArisGlobal, Glenn served as the CFO of Paya, where he led the team through a public listing and achieved unprecedented financial success. Prior to that role, he was the CFO of Opus, a Risk & Compliance SaaS company, where he closed the transaction for the sale of Opus’ third-party risk management platform. Glenn has a solid understanding of accounting principles, SEC reporting, and has held multiple Controllership roles.

Russ Schreiber
Chief Operating Officer
Based out of New York City, Russ is focused on our Professional Services organization along with multiple operational areas of the company in his newly created role of Chief Operating Officer.
Prior to joining ArisGlobal, Russ served as the Chief Operating Officer for the Altus Group’s Global Property Tax business. A former Big 4 consulting partner, executive and technology sales leader, Russ has held P&L responsibility for large divisions, implemented compliance and productivity measures, turned around challenged businesses and projects. He has held senior leadership roles with Altus, FICO, Swiss Re, and Ernst & Young in a career spanning close to 3 decades.

Kathleen Turland
Chief Legal Officer
Turland is a global strategic leader with more than 20 years of legal experience. She brings her broad range of legal and business skills to ArisGlobal, having worked with companies experiencing significant growth and expansion over the years, including General Electric, and FUSE Group. She started her legal career in New York, clerking for a Federal Court Judge, and working at two revered New York law firms.

Clint Wolfe
Chief Human Resources Officer

Rob Scott, MD
Chairman, ArisGlobal Advisory Board
Board Member
Dr. Scott has been appointed the Chairman of the Advisory Board, in addition to serving as a member of ArisGlobal’s Board of Directors. Dr. Scott joins the board with over 30 years of experience in the life sciences industry, most recently serving as the Chief Medical Officer and Head of Development at AbbVie, where he led a team of more than 4,000 individuals across 52 countries.

Georgia Papathomas, PhD
Advisory Board Member
Dr. Papathomas has over 40 years of experience in health, life sciences and technology, and is now an active investor, advisor, and board member. Dr. Papathomas recently retired from Johnson & Johnson as Senior Vice President and Global Head of Data Sciences, and previously held senior leadership positions at Boehringer Ingelheim, Pfizer and Lucent Technologies.

Juergen Schmider, MD, PhD
Advisory Board Member
Dr. Schmider is the President of Drug and Device Vigilance Consulting. He brings more than 20 years of life sciences industry experience to the Advisory Board, recently serving as Vice President of Safety Evaluation and Reporting at Pfizer after holding senior leadership roles at Hospira, Sanofi, Cephalon and Johnson & Johnson.

Paul Chew, MD
Advisory Board Member
Dr. Chew is currently the President of 1Rx Digipharm Advisory, with a decorated career spanning emerging and established life sciences organizations. Dr. Chew most recently held the position of Chief Medical Officer of Omada Health after serving as the SVP, Global Chief Medical Officer and Head of US R&D for Sanofi Pharmaceuticals.

Rick Riegel
Advisory Board Member
Mr. Riegel currently leads LMC Advisory and is the Executive Chairman of Actigraph, a leader in wearable solutions for clinical trials. He also serves as the Vice Chairman of the Board of Phlexglobal, a provider of clinical technology. Previously, as CEO of LIQUENT, Mr. Riegel was instrumental in transforming the company into a leader in regulatory technology and orchestrated its successful sale to PAREXEL, a global clinical research organization.

Vita Cassese
Advisory Board Member
Ms. Cassese is CEO of Mardon Management Advisors, a healthcare technology and analytics advisory firm. She has over 30 years of experience as an operating executive and strategist in the Life Sciences industry. Previously, Ms. Cassese served as CIO of Pfizer’s Worldwide Pharmaceuticals Group and was instrumental in the creation and leadership of Pfizer’s Global Innovation organization.

Daniel Berglund
Board Member
Partner at Nordic Capital
Daniel Berglund is a member of ArisGlobal’s Board of Directors and a Partner at Nordic Capital, having joined the firm in January 2010. Daniel has served on the boards of nine Nordic Capital portfolio companies. Daniel focuses on investment situations within Technology and Payments as well has Healthcare IT. Before joining Nordic Capital, Daniel worked at Bain & CO from 2007 to 2009, most recently as a Senior Associate. Daniel holds an MSc in Economics from the Stockholm School of Economics and Business Administration from the Ross School of Business at the University of Michigan.

Tom Thambert
Board Member
Director, Nordic Capital
Tom Thambert is a member of ArisGlobal’s Board of Directors and an Investment Director at Nordic Capital, having joined the firm in March 2014. Tom focuses on investments in healthcare technology and serves on the boards of the pharma technology companies ERT and Cytel. From 2010 to 2014 he worked in the Investment Banking Division at Rothschild in London. Tom holds a BSc in Economics and Business Administration from the Stockholm School of Economics.
Join our legacy of life science innovation